Bedside Snapshot
- Normal (Adult)
- 80–100 fL (same value in SI)
Lower in children: see the age table - Critical Values
- No universal critical value for MCV: interpret with hemoglobin, reticulocyte count and trend (typical; lab-specific)
- High Suggests
- B12 or folate deficiency
- Reticulocytosis: hemolysis, bleeding recovery
- Alcohol use, liver disease
- Drugs (hydroxyurea, methotrexate), MDS, hypothyroidism
- Low Suggests
- Iron deficiency: chronic GI or menstrual blood loss
- Thalassemia trait
- Anemia of inflammation
- Rare: sideroblastic anemia, lead exposure
- Act Now If
- Symptomatic anemia, active bleeding or new neurologic signs: treat perfusion and hemoglobin first; macrocytosis with numbness, ataxia or confusion needs B12 testing and prompt replacement
- Watch Out For
- A normal MCV does not exclude disease: mixed iron and B12/folate deficiency, early iron deficiency and recent transfusion can all look normocytic
Reference & Critical Ranges
Lab-specific ranges: Every lab sets its own interval, and it depends on the analyzer and the population. Use the range on your report. The values below are typical.
Reference ranges
| Population | Conventional | SI | Notes |
|---|---|---|---|
| Adult (men and women) | 80–100 fL | 80–100 fL | Same range for both sexes |
| Pregnancy | Same as adult | Same as adult | Anemia thresholds are trimester-specific in the 2024 WHO guideline: hemoglobin <11 g/dL in the first and third trimesters, <10.5 g/dL in the second. MCV rises slightly in normal pregnancy |
| Older adult | Same as adult | Same as adult | No separate range; new macrocytosis needs a cause |
| Neonate (day 1) | Term (40 weeks): mean 106 fL (SD 4) | Same | Fetal red cells are large; the more preterm, the higher (mean 119 fL at ≤25 weeks) |
| Infant (under 1 year) | 70.5–94.9 fL | Same | Wide range: MCV falls from neonatal values during the first year |
| Child (1 to under 4 years) | 72.8–85.2 fL | Same | Lowest MCV of childhood; adult cutoffs would label a normal toddler microcytic |
| Child (4 to under 14 years) | 77.4–89.9 fL | Same | Rises steadily with age |
| Adolescent (14 to under 21 years) | 77.6–95.7 fL | Same | No sex difference; approaching adult values |
Severity & critical values
| Level | Conventional | SI | What it means / typical findings |
|---|---|---|---|
| Microcytic | <80 fL | <80 fL | Iron deficiency until proven otherwise; also thalassemia trait and anemia of inflammation. Check ferritin |
| Normocytic | 80–100 fL | 80–100 fL | With anemia: acute blood loss, hemolysis, chronic kidney disease, inflammation or a mixed deficiency. Check reticulocytes |
| Macrocytic | >100 fL | >100 fL | Alcohol, liver disease, drugs, reticulocytosis, hypothyroidism, myelodysplasia, or B12/folate deficiency |
| Very high | >130 fL | >130 fL | Narrows the list to B12 or folate deficiency, hydroxyurea and antiretroviral therapy |
| Critical | None defined | None defined | MCV has no panic value. The danger is the hemoglobin, the bleeding or the neurologic deficit behind it |
Critical values: There is no universal critical value for MCV (typical; lab-specific). Don't act on the index. Act on the hemoglobin, the signs of bleeding and any new neurologic findings.
Conversion: Nothing to convert. fL is already an SI unit (1 fL = 10⁻¹⁵ L = 1 µm³).
Mean corpuscular volume (MCV)
MCV (fL) = Hematocrit (%) × 10 ÷ RBC count (×10⁶/µL)
Worked example: a hematocrit of 42% and an RBC count of 4.5 ×10⁶/µL give 93.3 fL, which is normocytic. A normal adult MCV runs 80–100 fL.
Causes of Abnormal Results
High (Macrocytosis >100 fL)
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Megaloblastic: vitamin B12 deficiency | Autoimmune gastritis (pernicious anemia), gastrectomy, bariatric or ileal surgery, vegan diet, metformin, acid suppressants, recreational nitrous oxide | Numbness, unsteady gait, falls, memory change, glossitis. Neurologic damage can occur with a normal MCV and no anemia |
| Megaloblastic: folate deficiency | Poor diet, alcohol use, celiac disease, inflammatory bowel disease, pregnancy, chronic hemolysis, methotrexate, trimethoprim, phenytoin | Same blood picture as B12 deficiency, but folate deficiency does not usually cause neurologic signs |
| Reticulocytosis | Hemolysis, recovery after hemorrhage | Reticulocytes are larger than mature cells. Absolute reticulocyte count >100,000/µL; hemolysis adds high indirect bilirubin and LDH, low haptoglobin |
| Alcohol use | Heavy, sustained drinking | MCV usually 100–110 fL, often before any anemia; high GGT; returns toward normal with abstinence |
| Liver disease | Cirrhosis, other chronic liver disease | Macrocytic target cells on the smear; jaundice, ascites |
| Drug effect on DNA synthesis | Hydroxyurea, methotrexate, azathioprine, zidovudine and other antiretrovirals, valproate, capecitabine | Check the medication list first; hydroxyurea and antiretrovirals can push MCV above 130 fL |
| Marrow disorder | Myelodysplastic syndrome (MDS), mostly older adults | Other cytopenias; abnormal neutrophils or platelets on the smear |
| Endocrine | Hypothyroidism | Anemia is normocytic or mildly macrocytic; check TSH |
Do not wait for macrocytosis to suspect B12 deficiency: Neurologic damage can come first. Subacute combined degeneration of the spinal cord can show up before anemia or a high MCV, or without either. New numbness, ataxia or cognitive change in an at-risk patient calls for B12 testing and prompt replacement. Don't give folate alone until B12 deficiency is excluded or treated, because folate can fix the blood count while the nerves keep getting worse.
Low (Microcytosis <80 fL)
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Iron deficiency | Chronic GI blood loss (colon cancer, peptic ulcer, angiodysplasia, NSAIDs), heavy menstrual loss, pregnancy, celiac disease, bariatric surgery, blood donation, poor intake | Low ferritin. The most common cause; MCH falls too and may be the more sensitive index |
| Thalassemia trait | α- or β-thalassemia carriers | MCV low out of proportion to a mild or absent anemia; RBC count normal or high; normal ferritin |
| Anemia of inflammation | Chronic infection, autoimmune disease, cancer, chronic kidney disease | Usually normocytic, sometimes mildly microcytic; ferritin normal or high because ferritin rises with inflammation |
| Sideroblastic anemia | Inherited disorders of heme synthesis (rare) | Iron is present but cannot be used; needs hematology review of the smear and marrow |
| Lead exposure | Children with pica | Often coexists with iron deficiency and worsens it; basophilic stippling; order a blood lead level |
Iron deficiency in a man or a postmenopausal woman: about a third have an underlying cause, most often in the GI tract, including colon cancer. Microcytic anemia in these patients needs GI evaluation, not just iron.
Normal MCV with anemia (normocytic)
Think of acute blood loss, before reticulocytes have had time to rise. Then early hemolysis, chronic kidney disease, anemia of inflammation, marrow suppression or infiltration. Mixed iron plus B12/folate deficiency belongs on that list too, since small and large cells cancel out into a normal MCV.
Interpretation & Bedside Approach
Step-by-step approach
- Is it real? Check the analyzer flags and how old the sample is. Severe hyperglycemia, cold agglutinins, marked leukocytosis and a sample left at room temperature can all push the MCV up falsely.
- How sick is the patient? The MCV never drives emergency care. Hemoglobin, perfusion, active bleeding and neurologic signs do. On scene and in transport, you manage perfusion and bleeding first. The MCV and its workup belong to the receiving team.
- Acute vs chronic, and the trend: compare with prior CBCs. A microcytic or macrocytic anemia builds over weeks to months. A sudden hemoglobin drop with a stable, normal MCV fits acute loss.
- Calculate derived values: absolute reticulocyte count, and the Mentzer index when the MCV is low.
- Classify: confirm anemia by the World Health Organization (WHO) thresholds (hemoglobin <13 g/dL in men, <12 g/dL in nonpregnant women, and <11 g/dL in the first and third trimesters of pregnancy and <10.5 g/dL in the second), then sort by MCV: <80, 80–100 or >100 fL.
- Escalate or dispose: Symptomatic anemia, bleeding, hemolysis or neurologic signs need same-day care. A stable abnormal MCV in a well patient needs the next test and follow-up.
Pattern and next test
| Pattern | Suggests | Next step |
|---|---|---|
| Low MCV, low ferritin | Iron deficiency | Find the source: GI evaluation and celiac testing in men and postmenopausal women |
| Low MCV, normal ferritin, RBC count normal or high | Thalassemia trait | Hemoglobin electrophoresis; avoids needless iron and endoscopy. Alpha-thalassemia trait has a normal electrophoresis, so consider alpha-globin gene testing if suspicion persists |
| Low or normal MCV, chronic illness, ferritin normal or high | Anemia of inflammation | Transferrin saturation; treat the underlying disease |
| High MCV, reticulocytes >100,000/µL | Hemolysis or recovery from bleeding | Bilirubin, LDH, haptoglobin; if no hemolysis, look for blood loss |
| High MCV, low B12 or folate | Megaloblastic anemia | Smear for macro-ovalocytes and hypersegmented neutrophils; find the cause of the deficiency |
| High MCV, normal B12 and folate, low reticulocytes | Alcohol, liver disease, hypothyroidism, drugs, MDS | GGT, liver tests, TSH, medication review, smear; hematology if other cytopenias |
RDW sharpens the same question. A high RDW with a low MCV points toward iron deficiency. A normal RDW with a low MCV points toward thalassemia trait. A high RDW with a normal MCV can mean early or mixed deficiency. Read RDW.
Thalassemia trait vs iron deficiency
Mentzer index
MCV (fL) ÷ RBC count (×10⁶/µL)
Under 13 suggests thalassemia trait. Over 13 suggests iron deficiency. Treat it as a screening clue and nothing more. Confirm with ferritin and, if iron is normal, hemoglobin electrophoresis.
B12 and folate results
- Total B12 (NICE NG239, 2024): <180 ng/L (pg/mL) confirms deficiency, 180–350 is indeterminate (add methylmalonic acid), >350 makes deficiency unlikely. Use your laboratory's cutoffs where they differ.
- Nitrous oxide use: reach for homocysteine or methylmalonic acid first. The serum B12 level can look normal.
- Folate: serum folate >4 ng/mL effectively excludes deficiency. A level <2 ng/mL is diagnostic. Cutoffs are lab-dependent.
Smear clues
Special Populations
| Population | What changes | Clinical implication |
|---|---|---|
| Neonates & infants | MCV is highest at birth (higher still in preterm infants) and falls through the first year | Use age-specific ranges; an adult-range MCV is not normal in a 1-year-old |
| Children & adolescents | Lower limit is about 73 fL at 1 to under 4 years and rises toward adult values in the teens | Microcytosis in a toddler is usually iron deficiency; ask about diet and pica, and consider lead |
| Pregnancy | Iron and folate needs rise; reference range unchanged, though MCV rises slightly | Low MCV prompts ferritin, then electrophoresis if iron is normal; NICE advises active B12 (holotranscobalamin) as the first B12 test in pregnancy |
| Older adults | Iron deficiency is common and multifactorial; MDS and B12 deficiency become more frequent | Microcytosis needs a GI evaluation; new macrocytosis needs B12, folate, medication review and, with cytopenias, hematology |
| CKD / dialysis | Anemia is usually normocytic, often with functional iron deficiency | Commonly used diagnostic thresholds are TSAT <20% with ferritin <100 ng/mL (<200 ng/mL on hemodialysis), historically called absolute iron deficiency; KDIGO 2026 proposes the term systemic iron deficiency. They are diagnostic cutoffs, not treatment triggers. KDIGO 2026 suggests starting iron at ferritin <100 ng/mL with TSAT <40%, or ferritin 100–299 ng/mL with TSAT <25% (not on dialysis or peritoneal dialysis); on hemodialysis, ferritin ≤500 ng/mL with TSAT ≤30%. Treat per the KDIGO 2026 thresholds above; iron decisions in CKD are made with nephrology. |
| Liver disease, alcohol use | Macrocytosis common, often without anemia | Still check B12 and folate; poor diet and alcohol cause folate deficiency |
| Other: bariatric surgery, hydroxyurea or antiretroviral therapy | Iron and B12 malabsorption after bypass; expected rise in MCV on hydroxyurea and some antiretrovirals | Bariatric patients can have both deficiencies with a normal MCV; a drug-related high MCV is expected, not a new diagnosis |
Interfering Factors & Pitfalls
Collection & handling
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Sample held at room temperature | ↑ | Red cells swell in EDTA over time: in a 2025 study MCV rose with storage at about 22 °C (72 °F) and stayed stable at 4 °C (39 °F) | Run promptly or refrigerate; note delayed or interfacility samples |
| Recent transfusion | Shifts toward donor values | Donor cells mix with the patient's own | Use the pre-transfusion CBC to classify the anemia |
Physiologic / biologic
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Cold agglutinins | ↑ MCV, ↓ RBC count, ↑ MCHC | Clumped cells are counted as single large cells | Warm the sample to 37 °C (98.6 °F) and rerun; hemoglobin is the least affected value |
| Severe hyperglycemia | ↑ | Glucose-loaded cells swell when diluted in the analyzer | Expect it in DKA or HHS; reinterpret once glucose is corrected |
| Marked leukocytosis | ↑ | White cells are counted with red cells | Smear review |
| Reticulocytosis | ↑ (true) | Reticulocytes are larger than mature red cells | Check reticulocyte count before chasing B12 |
| Giant platelets or platelet fragments | ↓ (false) | Some analyzers count them as small red cells | Check the smear before reading a low MCV as microcytosis |
Medications & supplements
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Hydroxyurea, zidovudine, methotrexate, azathioprine, valproate | ↑ (true) | Impaired DNA synthesis in red cell precursors | Expected on therapy; still check B12/folate if symptoms fit |
| Metformin, proton pump inhibitors, H₂ blockers, nitrous oxide | ↑ via B12 deficiency, or normal | Reduce B12 absorption or inactivate B12 | Test B12 on long-term use or with neuropathy |
| B12 supplements | Falsely reassuring B12 level | Supplements raise the level without treating malabsorption | Ask about over-the-counter B12 before reading the result |
Common misinterpretations
- "Normal MCV, so no deficiency": Early iron deficiency, mixed iron plus B12/folate deficiency and a recent transfusion can all look normocytic.
- "Microcytic, so give iron": Confirm with ferritin. Thalassemia trait does not respond to iron.
- "Macrocytic, so it is alcohol": Rule out B12/folate deficiency, reticulocytosis and drug effect before you blame alcohol.
- "No anemia, so no B12 deficiency": Neurologic damage can happen with a normal blood count.
Physiology & Test Basics
What it measures
Start here for the three red cell indices. Each one describes the average red cell, and each sibling page goes deeper on its own index. RDW (spread of cell sizes) is the companion index.
| Index | What it measures | Adult normal | Read it for |
|---|---|---|---|
| MCV (this page) | Average cell volume, fL | 80–100 fL | Cell size: microcytic, normocytic or macrocytic |
| MCH | Average hemoglobin mass per cell, pg | 27–33 pg | Hemoglobin content; it rises with MCV, so adds little in macrocytosis |
| MCHC | Average hemoglobin concentration inside cells, g/dL | 32–36 g/dL (320–360 g/L) | Cell density: a low value is hypochromia; a high value is spherocytosis, sickle cell disease or artifact |
Physiology & regulation
- Hemoglobin synthesis: Precursors keep dividing until the cell holds enough hemoglobin. Short on iron or globin? They divide more and make small, pale cells (low MCV and MCH).
- DNA synthesis: Copying DNA takes B12 and folate. Run short and the cells come out large (megaloblastic).
- Cell hydration: MCHC tracks water content. Cells that lose membrane or water (spherocytes, sickle cells) turn dense.
- Cell age: Young cells run big. Reticulocytes outsize mature cells, so a burst of production pushes the MCV up.
- Slow turnover: Red cells live about 120 days. Indices move over weeks to months.
How it is measured
- Specimen: whole blood in a lavender-top tube (K₂EDTA), part of every CBC. Fill to the line and invert gently. No fasting needed.
- Method: Automated analyzers measure each cell's volume (impedance or light scatter) and its hemoglobin, then calculate MCH and MCHC. Hematocrit comes from MCV × RBC count. The formulas in the Reference section are the manual method and still check the result. Point-of-care hemoglobin devices used on scene or in transport generally don't report MCV, MCH or MCHC. Those indices come from a full CBC at the sending facility, so note its draw time.
Why it matters
In the ED, the ICU and in transport, the MCV tells you whether an anemia is new or long-standing. It also points to what's behind it: chronic GI blood loss, B12 deficiency, alcohol, hemolysis or a bad sample.
Clinical Pearls
Read the MCV for chronicity: Iron loss builds slowly, over weeks to months, before the cells shrink. A low MCV in a bleeding patient points to loss that was already going on before today's bleed. Hand it to the receiving team.
Ask about nitrous oxide: Recreational nitrous oxide knocks out B12. Think of it in a young patient with new numbness, weakness or an unsteady gait. The MCV may look normal, and so may the B12 level. Homocysteine or methylmalonic acid confirms it.
Draw before you transfuse: If an anemia workup is ordered, draw before the first unit goes in. Send the CBC, the reticulocyte count and the iron, B12 and folate samples. Once donor blood is in, the indices partly reflect donor cells.
DKA and HHS can fake macrocytosis: Glucose that high swells the cells inside the analyzer, and the MCV reads high. Don't start a macrocytosis workup from a CBC drawn at the peak of a hyperglycemic crisis.
Pair MCV with GGT: A mild macrocytosis (100–110 fL) with a raised GGT and no anemia: a common pattern in heavy drinkers. Ask about alcohol.
Small cells, normal iron: A low MCV with normal ferritin and a near-normal hemoglobin is often thalassemia trait. Chart it, so the patient doesn't get another round of iron or a scope they don't need.
Older adult with a high MCV and low counts: Other cytopenias plus a high MCV and normal B12 and folate: think myelodysplasia. Flag it for hematology rather than repeating the vitamins.
Do not let a normal MCV reassure you in acute bleeding: The hemoglobin and the indices trail the bleeding. Treat shock on clinical signs and repeat the CBC.
References
- Maner, B. S., Killeen, R. B., & Moosavi, L. (2024). Mean corpuscular volume. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK545275/
- Tahmasebi, H., Higgins, V., Bohn, M. K., Hall, A., & Adeli, K. (2020). CALIPER hematology reference standards (I). American Journal of Clinical Pathology, 154(3), 330–341. https://doi.org/10.1093/ajcp/aqaa059
- Christensen, R. D., Jopling, J., Henry, E., & Wiedmeier, S. E. (2008). The erythrocyte indices of neonates, defined using data from over 12,000 patients in a multihospital health care system. Journal of Perinatology, 28(1), 24–28. (landmark study) https://doi.org/10.1038/sj.jp.7211852
- Snook, J., Bhala, N., Beales, I. L. P., Cannings, D., Kightley, C., Logan, R. P., et al. (2021). British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut, 70(11), 2030–2051. https://doi.org/10.1136/gutjnl-2021-325210
- National Institute for Health and Care Excellence. (2024). Vitamin B12 deficiency in over 16s: Diagnosis and management (NICE guideline NG239). https://www.nice.org.uk/guidance/ng239
- Nagao, T., & Hirokawa, M. (2017). Diagnosis and treatment of macrocytic anemias in adults. Journal of General and Family Medicine, 18(5), 200–204. https://doi.org/10.1002/jgf2.31
- Al-Najdawi, M. A., Fararjeh, A. S., & Khataibeh, M. (2025). Impact of pre-analytical variables (temperature, agitation, storage duration and blood-to-anticoagulant ratio) on complete blood count test reliability. Medicine and Pharmacy Reports, 98(4), 452–460. https://doi.org/10.15386/mpr-2880
- Mentzer, W. C. (1973). Differentiation of iron deficiency from thalassaemia trait. The Lancet, 1(7808), 882. (landmark derivation paper) https://doi.org/10.1016/s0140-6736(73)91446-3
- KDIGO. (2026). KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (full text, PDF). https://kdigo.org/wp-content/uploads/2026/04/KDIGO-2026-Anemia-in-CKD-Guideline.pdf
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
AI was used to assist in organizing, paraphrasing, and formatting this information.